Qiagen Plans Greater Push into Molecular Dx, Bolsters Sales Force to Peddle New Products | GenomeWeb

Qiagen has launched a new avian flu molecular diagnostic test and intends to launch another 12 assays for bacterial and viral infections within the next four months as it continues to focus its business on the diagnostics market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.